This source features Dr. Pawan Kumar, discussing the alarming global surge in antifungal-resistant skin infections. He highlights a specific, highly resilient fungal species known as Trichophyton indotineae, which has evolved to withstand standard treatments such as terbinafine. The text outlines how this variant causes intense inflammation and extensive bodily lesions that persist far longer than typical infections. To combat this resistance, the doctor details various medical strategies, including higher dosages of alternative drugs like itraconazole and the use of pulse therapy. Finally, the presentation emphasises that overcoming this epidemic requires strict patient compliance, improved hygiene practices, and prolonged treatment regimens involving combination therapies.